Novel compounds are provided in the form of nucleoside pyrophosphate and triphosphate analogs. In these analogs, the pyrophosphate or triphosphate group is replaced with a moiety that is isosterically and electronically identical thereto, but is hydrolytically and enzymatically more stable. The compounds are useful as therapeutic agents, e.g., as antiviral agents, anticancer agents, metabolic moderators and the like. The invention also provides pharmaceutical compositions containing a compound of the invention as an active agent, and in addition provides methods of treating disease, including viral infections, cancer, bacterial infections, inflammatory and/or autoimmune diseases, and the like, by administering a compound of the invention to a patient in need of such treatment.

Os compostos da novela são fornecidos no formulário de analogs do pyrophosphate e do triphosphate do nucleoside. Nestes analogs, o grupo do pyrophosphate ou do triphosphate é substituído com um moiety que seja isosterically e eletronicamente idêntico a isso, mas é hydrolytically e enzymatically mais estável. Os compostos são úteis como agentes therapeutic, por exemplo, como agentes antiviral, agentes anticancer, moderators metabolic e o gosto. A invenção fornece também as composições pharmaceutical que contêm um composto da invenção como um agente ativo, e além fornece métodos de tratar a doença, including infecções viral, cancer, infecções bacterianas, doenças inflammatory e/ou autoimmune, e o gosto, administrando um composto da invenção a um paciente na necessidade de tal tratamento.

 
Web www.patentalert.com

< Sulfur tolerant lean NOx trap

< Polarizable electrode for electrical double-layer capacitor

> Multimetal cyanide compounds, their preparation and their use

> Positive active material for rechargeable lithium battery and method of preparing same

~ 00083